In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E- deficient mice

Journal of Vascular Research

Volumn 45, Issue 2, 2008, Pages 123-128

  Yasuda, Satoshi ^a   Ikuta, Kenjiro ^c   Uwatoku, Toyokazu ^b   Oi, Keiji ^b   Abe, Kohtaro ^b   Hyodo, Fuminori ^c   Yoshimitsu, Kengo ^d   Sugimura, Kohtaro ^e   Utsumi, Hideo ^c   Katayama, Yoshiki ^c   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY HOSPITAL   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Atherosclerosis; Contrast agent; Magnetic resonance imaging

Indexed keywords

APOLIPOPROTEIN E; EVANS BLUE; GADOLINIUM PENTETATE; CONTRAST MEDIUM; DRUG DERIVATIVE; EVANS BLUE DTPA GADOLINIUM; EVANS BLUE-DTPA-GADOLINIUM; ORGANOMETALLIC COMPOUND; PENTETIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; IMAGE ANALYSIS; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; VASCULAR LESION; ANIMAL; AORTA; ATHEROSCLEROSIS; C57BL MOUSE; DISEASE MODEL; EVALUATION; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; METABOLISM; METHODOLOGY; MOUSE MUTANT; PATHOLOGY; TIME;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; TIME FACTORS;

EID: 40749098635     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109930     Document Type: Article

References (17)

1. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
2. Shimokawa H: Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 1999;31:23-37.
3. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, Mintz GS, Nagata S: Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006;47:2108-2111.
4. Ong AT, Serruys PW: Technology insight: an overview of research in drug-eluting stents. Nat Clin Pract Cardiovasc Med 2005;2:647-658.
5. Lipinski MJ, Fuster V, Fisher EA, Fayad ZA: Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging. Nat Clin Pract Cardiovasc Med 2004;1:48-55.
6. Fuster V, Kim RJ: Frontiers in cardiovascular magnetic resonance. Circulation 2005;112:135-144.
7. Sipkins DA, Gijbels K, Tropper FD, Bednarski M, Li KC, Steinman L: ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. J Neuroimmunol 2000;104:1-9.
8. Yu X, Song SK, Chen J, Scott MJ, Fuhrhop RJ, Hall CS, Gaffney PJ, Wickline SA, Lanza GM: High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn Reson Med 2000;44:867-872.
9. 3-targeted nanoparticles. Magn Reson Med 2000;44:433-439.
10. Yamamoto T, Ikuta K, Oi K, Abe K, Uwatoku T, Murata M, Shigetani N, Yoshimitsu K, Shimokawa H, Katayama Y: First functionalized MRI contrast agent recognizing vascular lesions. Anal Sci 2004;20:5-7.
11. Christensen BC, Chemnitz J, Tkocz I: Repair in arterial tissue. Electron microscopy of Evans blue vital stained embolectomy catheter lesion of the rabbit thoracic aorta. Acta Pathol Microbiol Scand 1976;84:355-357.
12. Yamamoto T, Ikuta K, Oi K, Abe K, Uwatoku T, Hyodo F, Murata M, Shigetani N, Yoshimitsu K, Shimokawa H, Utsumi H, Katayama Y: In vivo MR detection of vascular endothelial injury using a new class of MRI contrast agent. Bioorg Med Chem Lett 2004;14:2787-2790.
13. Morikawa K, Matoba T, Kubota H, Hatanaka M, Fujiki T, Takahashi S, Takeshita A, Shimokawa H: Influence of diabetes mellitus, hypercholesterolemia, and their combination on EDHF-mediated responses in mice. J Cardiovasc Pharmacol 2005;45:485-490.
14. Tsopelas C, Sutton R: Why certain dyes are useful for localizing the sentinel lymph node. J Nucl Med 2002;43:1377-1382.
15. Crauwels HM, Van Hove CE, Holvoet P, Herman AG, Bult H: Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI. Cardiovasc Res 2003;59:189-199.
16. Chaabane L, Pellet N, Bourdillon MC, Desbleds Mansard C, Sulaiman A, Hadour G, Thivolet-Bejui F, Roy P, Briguet A, Douek P, Canet Soulas E: Contrast enhancement in atherosclerosis development in a mouse model: in vivo results at 2 Tesla. MAGMA 2004;17:188-195.
17. Biswas J, Nelson CB, Runge VM, Wintersperger BJ, Baumann SS, Jackson CB, Patel T: Brain tumor enhancement in magnetic resonance imaging: comparison of signal-tonoise ratio (SNR) and contrast-to-noise ratio (CNR) at 1.5 versus 3 tesla. Invest Radiol 2005;40:792-797.